178 related articles for article (PubMed ID: 18562441)
1. Duloxetine-induced hypomania: case report and brief review of the literature on SNRIs-induced mood switching.
Peritogiannis V; Antoniou K; Mouka V; Mavreas V; Hyphantis TN
J Psychopharmacol; 2009 Jul; 23(5):592-6. PubMed ID: 18562441
[TBL] [Abstract][Full Text] [Related]
2. Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.
Dunner DL; D'Souza DN; Kajdasz DK; Detke MJ; Russell JM
J Affect Disord; 2005 Jul; 87(1):115-9. PubMed ID: 15967235
[TBL] [Abstract][Full Text] [Related]
3. Manic switching in patients receiving duloxetine.
de Dios C; Ezquiaga E
Am J Psychiatry; 2007 Jul; 164(7):1121. PubMed ID: 17606669
[No Abstract] [Full Text] [Related]
4. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
Stahl SM; Grady MM; Moret C; Briley M
CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
[TBL] [Abstract][Full Text] [Related]
5. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
6. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
[TBL] [Abstract][Full Text] [Related]
7. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
Lee SI; Keltner NL
Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
[No Abstract] [Full Text] [Related]
8. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
[TBL] [Abstract][Full Text] [Related]
9. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-induced mania in bipolar patients: identification of risk factors.
Henry C; Sorbara F; Lacoste J; Gindre C; Leboyer M
J Clin Psychiatry; 2001 Apr; 62(4):249-55. PubMed ID: 11379838
[TBL] [Abstract][Full Text] [Related]
11. Venlafaxine-associated hypomania in unipolar depression.
Chand PK; Kalyani GS; Murthy P
Can J Psychiatry; 2004 Jul; 49(7):496. PubMed ID: 15362257
[No Abstract] [Full Text] [Related]
12. Mania following antidepressant discontinuation in depression: two case reports.
Kwok CSN; Lim LEC
Australas Psychiatry; 2017 Dec; 25(6):617-621. PubMed ID: 28976215
[TBL] [Abstract][Full Text] [Related]
13. Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series.
Dell'osso B; Mundo E; Marazziti D; Altamura AC
J Psychopharmacol; 2008 Mar; 22(2):210-3. PubMed ID: 18208931
[TBL] [Abstract][Full Text] [Related]
14. An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
Wohlreich MM; Martinez JM; Mallinckrodt CH; Prakash A; Watkin JG; Fava M
J Clin Psychopharmacol; 2005 Dec; 25(6):552-60. PubMed ID: 16282837
[TBL] [Abstract][Full Text] [Related]
15. Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.
Stovall R; Brahm NC; Crosby KM
Consult Pharm; 2009 Oct; 24(10):765-8. PubMed ID: 20017411
[TBL] [Abstract][Full Text] [Related]
16. [Dermatological side effects during therapy with serotonin noradrenaline reuptake inhibitors].
Gross CM; Klöcker M; Jakob T; Klecha D
Nervenarzt; 2008 Nov; 79(11):1304, 1307-9. PubMed ID: 18958440
[TBL] [Abstract][Full Text] [Related]
17. Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine -- case report.
Himmighoffen H; Seifritz E; Boeker H
Pharmacopsychiatry; 2011 Mar; 44(2):75-6. PubMed ID: 21161885
[No Abstract] [Full Text] [Related]
18. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Ishigooka J
Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
Rabasseda X
Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
[TBL] [Abstract][Full Text] [Related]
20. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
